Insmed Inc. buy Royal Bank of Canada
Start price
25.02.25
/
50%
€76.00
Target price
25.02.26
€95.22
Performance (%)
88.16%
Price
18.12.25
€130.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Insmed Inc. has seen massive gains of 88.16%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -21.687% | -21.687% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $100.00 price target on the stock.
Ratings data for INSM provided by MarketBeat